Acquired angioedema;Les angiœdèmes bradykiniques acquis

Revue de Medecine Interne

Volumn 31, Issue SUPPL.1, 2010, Pages

  Fain, O ^a  

^a UNIVERSITÉ PARIS 13   (France)

Author keywords

Acquired C1 inhibiteur deficiency; Angioedema; Angiotensin converting enzyme inhibitor; Lupus; Monoclonal gammopathies

Indexed keywords

ANGIONEUROTIC EDEMA; ARTICLE; GAMMOPATHY; HEMATOLOGIC DISEASE; HUMAN;

BRADYKININ;

ANGIOEDEMA; BRADYKININ; HUMANS;

EID: 79951987121     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2010.03.005     Document Type: Article

References (23)

1. Cugno M., Zanichelli A., Foieni F., Caccia S., Cicardi M. C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med 2009, 15(2):69-78.
2. Cicardi M., Zingale L.C., Bergamaschini L., Agostoni A. Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment. Arch Intern Med 2004, 164:910-913.
3. Bork K., Wulff K., Hardt J., Witzke G., Staubach P. Hereditary angioedema caused by missense mutations in the factor XII gene: clinical features, trigger factors, and therapy. J Allergy Clin Immunol 2009, 124:129-134.
4. Bouillet L., Longhurst H., Boccon-Gibod I., Bork K., Bucher C., Bygum A., et al. Disease expression in women with hereditary angioedema. Am J Obstet Gynecol 2008, 199:484.e1-484.e4.
5. Rousset-Jablonski C., Thalabard J.C., Gompel A. Tamoxifen contraindicated in women with hereditary angioedema?. Ann Oncol 2009, 20:1281-1282.
6. Cugno M., Castelli R., Cicardi M. Angioedema due to acquired C1-inhibitor deficiency: a bridging condition between autoimmunity and lymphoproliferation. Autoimmun Rev 2008, 8:156-159.
7. Cicardi M., Zingale L.C., Pappalardo E., Folcioni A., Agostoni A. Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies. Medecine 2003, 82:274-281.
8. Fremeaux-Bacchi V., Guinnepain M.T., Cacoub P., Dragon-Durey M.A., Mouthon L., Blouin J., et al. Prevalence of monoclonal gammopathy in patients presenting with acquired angioedema type 2. Am J Med 2002, 113:194-199.
9. Bibi-Triki T., Eclache V., Frilay Y., Stirnemann J., Frémeaux-Bacchi V., Fain O. Deficit acquis en C1 inhibiteur associé à un syndrome lymphoprolifératif: 4 cas. Rev Med Interne 2004, 25:667-672.
10. Hory B., Panouse-Perrin J., Dupond J.L., Leconte des Floris R. Déficit acquis en inhibiteur de la C1 estérase et syndrome lymphoprolifératif. Rev Med Interne 1985, 6:266-271.
11. Grosbois B., Goasguen J., Leblay R. Déficit acquis en inhibiteur de la C1 estérase et syndromes lymphoprolifératifs malins. Rev Med Interne 1985, 6:464.
12. Bain B.J., Catovsky D., Ewan P.W. Acquired angioedema as the presenting feature of lymphoproliferative disorders of mature B-lymphocytes. Cancer 1993, 72:3318-3322.
13. Hauptmann G., Petitjean F., Lang J.M., Oberling F. Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy. Clin Exp Immunol 1979, 37:523-531.
14. Ziakas P.D., Giannouli S., Psimenou E., Evangelia K., Tzioufas A.G., Voulgarelis M. Acquired angioedema: a new target for rituximab?. Haematologica 2004, 89:104-110.
15. Levi M., Hack C.E., van Oers M.H. Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency. Am J Med 2006, 119:e3-5.
16. Rottem M., Mader R. Successful use of etanercept in acquired angioedema in a patient with psoriatic arthritis. J Rheumatol 2010, 37:209.
17. Kohler P.F., Percy J., Campion W.M., Smyth C.J. Hereditary angioedema and " familial" lupus erythematosus in identical twin boys. Am J Med 1974, 56:406-411.
18. Koide M., Shirahama S., Tokura Y., Takigawa M., Hayakawa M., Furukawa F. Lupus erythematosus associated with C1 inhibitor deficiency. J Dermatol 2002, 29:503-507.
19. Khan S., Tarzi M.D., Doré P.C., Sewell W.A., Longhurst H.J. Secondary systemic lupus erythematosus: an analysis of 4 cases of uncontrolled hereditary angioedema. Clin Immunol 2007, 123:14-17.
20. Donaldson V.H., Hess E.V. Effect of danazol on lupus-erythematosus-like disease in hereditary angioneurotic oedema. Lancet 1980, 2:1145.
21. Fretwell M.D., Altman L.C. Exacerbation of a lupus-erythematosus-like syndrome during treatment of non-C1-esterase-inhibitor-dependent angioedema with danazol. J Allergy Clin Immunol 1982, 69:306-310.
22. Cacoub P., Fremeaux-Bacchi V., De Lacroix I., Guillien F., Kahn M.F., Kazatchkine M.D., et al. A new type of acquired C1 inhibitor deficiency associated with systemic lupus erythematosus. Arthritis Rheum 2001, 44:1836-1840.
23. Nakamura S., Yoshinari M., Saku Y., Hirakawa K., Miishima C., Murai K., et al. Acquired C1 inhibitor deficiency associated with systemic lupus erythematosus affecting the central nervous system. Ann Rheum Dis 1991, 50:713-716.